|View printer-friendly version|
|January 10, 2006 1:22 p.m.|
|Teva and IVAX Announce that FTC Review Process Continues on Track and Merger Closing is Expected Shortly|
Jerusalem, Israel and Miami, Florida, January 10, 2006 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) and IVAX Corporation (AMEX: IVX) announced today that the closing date of the merger has been rescheduled and will take place on the third business day following their public announcement that the U.S. Federal Trade Commission ("FTC") has accepted the consent order which Teva and IVAX have signed. The transaction cannot be closed without the acceptance of the consent order by the Commissioners of the FTC, and such acceptance has not as yet been obtained.